News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
848,601 Results
Type
Article (86577)
Company Profile (702)
Press Release (761322)
Multimedia
Podcasts (133)
Webinars (14)
Section
Business (232720)
Career Advice (4128)
Deals (39728)
Drug Delivery (129)
Drug Development (91003)
Employer Resources (198)
FDA (18127)
Job Trends (17342)
News (396545)
Policy (39763)
Tag
Academia (3001)
Academic (2)
Accelerated approval (7)
Adcomms (31)
Allergies (96)
Alliances (56864)
ALS (107)
Alzheimer's disease (1518)
Antibody-drug conjugate (ADC) (166)
Approvals (18075)
Artificial intelligence (348)
Autoimmune disease (30)
Automation (17)
Bankruptcy (405)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (120)
Biotechnology (481)
Bladder cancer (88)
Brain cancer (33)
Breast cancer (325)
Cancer (2568)
Cardiovascular disease (217)
Career advice (3535)
Career pathing (34)
CAR-T (187)
Cell therapy (523)
Cervical cancer (22)
Clinical research (73619)
Collaboration (960)
Company closure (2)
Compensation (603)
Complete response letters (30)
COVID-19 (2876)
CRISPR (57)
C-suite (289)
Cystic fibrosis (111)
Data (2510)
Decentralized trials (2)
Denatured (46)
Depression (58)
Diabetes (312)
Diagnostics (6943)
Digital health (23)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (158)
Drug pricing (138)
Drug shortages (33)
Duchenne muscular dystrophy (110)
Earnings (97361)
Editorial (47)
Employer branding (25)
Employer resources (167)
Events (130522)
Executive appointments (818)
FDA (19626)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (864)
Gene editing (133)
Generative AI (36)
Gene therapy (390)
GLP-1 (873)
Government (5183)
Grass and pollen (6)
Guidances (176)
Healthcare (20895)
Huntington's disease (26)
IgA nephropathy (32)
Immunology and inflammation (158)
Immuno-oncology (2)
Indications (31)
Infectious disease (3041)
Inflammatory bowel disease (160)
Inflation Reduction Act (12)
Influenza (59)
Intellectual property (106)
Interviews (813)
IPO (17851)
IRA (52)
Job creations (5190)
Job search strategy (2861)
Kidney cancer (11)
Labor market (47)
Layoffs (569)
Leadership (24)
Legal (10120)
Liver cancer (82)
Lung cancer (361)
Lymphoma (174)
Machine learning (9)
Management (65)
Manufacturing (386)
MASH (88)
Medical device (14657)
Medtech (14662)
Mergers & acquisitions (22478)
Metabolic disorders (839)
Multiple sclerosis (93)
NASH (23)
Neurodegenerative disease (126)
Neuropsychiatric disorders (36)
Neuroscience (2167)
NextGen: Class of 2025 (7682)
Non-profit (5084)
Now hiring (42)
Obesity (446)
Opinion (279)
Ovarian cancer (86)
Pain (106)
Pancreatic cancer (91)
Parkinson's disease (172)
Partnered (25)
Patents (268)
Patient recruitment (126)
Peanut (51)
People (65413)
Pharmaceutical (143)
Pharmacy benefit managers (24)
Phase I (22723)
Phase II (31979)
Phase III (24068)
Pipeline (1538)
Policy (189)
Postmarket research (3552)
Preclinical (10267)
Press Release (72)
Prostate cancer (116)
Psychedelics (39)
Radiopharmaceuticals (271)
Rare diseases (454)
Real estate (7393)
Recruiting (75)
Regulatory (26874)
Reports (61)
Research institute (2661)
Resumes & cover letters (649)
Rett syndrome (7)
RNA editing (8)
RSV (50)
Schizophrenia (84)
Series A (150)
Series B (100)
Service/supplier (30)
Sickle cell disease (61)
Special edition (21)
Spinal muscular atrophy (166)
Sponsored (35)
Startups (4295)
State (2)
Stomach cancer (16)
Supply chain (77)
Tariffs (59)
The Weekly (85)
Vaccines (831)
Venture capitalists (46)
Weight loss (309)
Women's health (42)
Worklife (20)
Date
Today (127)
Last 7 days (810)
Last 30 days (3912)
Last 365 days (35497)
2025 (14140)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1271)
Alabama (62)
Alaska (7)
Arizona (272)
Arkansas (14)
Asia (50224)
Australia (8844)
California (6992)
Canada (2169)
China (598)
Colorado (300)
Connecticut (316)
Delaware (174)
Europe (115292)
Florida (1019)
Georgia (235)
Hawaii (1)
Idaho (65)
Illinois (662)
India (31)
Indiana (351)
Iowa (13)
Japan (189)
Kansas (115)
Kentucky (28)
Louisiana (16)
Maine (72)
Maryland (1015)
Massachusetts (5325)
Michigan (261)
Minnesota (442)
Mississippi (2)
Missouri (94)
Montana (31)
Nebraska (26)
Nevada (74)
New Hampshire (70)
New Jersey (1944)
New Mexico (31)
New York (1962)
North Carolina (1178)
North Dakota (10)
Northern California (3014)
Ohio (233)
Oklahoma (15)
Oregon (48)
Pennsylvania (1514)
Puerto Rico (15)
Rhode Island (36)
South America (1653)
South Carolina (29)
South Dakota (1)
Southern California (2581)
Tennessee (111)
Texas (1047)
United States (26524)
Utah (205)
Virginia (186)
Washington D.C. (74)
Washington State (634)
West Virginia (3)
Wisconsin (76)
There are 848,601 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Lymphoma
Roche’s Genentech Fails to Win Adcomm Backing for Columvi Expansion
The ODAC cited concerns with patient populations in clinical trials used to support the proposed expansion. Johnson & Johnson fared better, with the FDA’s cancer advisors voting to recommend Darzalex in patients with a certain type of multiple myeloma.
May 21, 2025
·
2 min read
·
Tristan Manalac
Layoff Tracker
Schrödinger Downsizes by 7% in Savings Push
Follow along as
BioSpace
tracks job cuts and restructuring initiatives throughout 2025.
May 21, 2025
·
209 min read
·
BioSpace Editorial Staff
Press Releases
Coave Therapeutics Establishes New Scientific Advisory Board to Accelerate Innovation in Genetic Medicines for Eye and CNS Diseases
May 21, 2025
·
4 min read
Press Releases
Verona Pharma Announces June 2025 Investor Conference Participation
May 21, 2025
·
1 min read
Press Releases
Zymeworks Announces Participation in Upcoming June 2025 Investor Conferences
May 21, 2025
·
2 min read
Press Releases
Biodesix to Participate in Upcoming Investor Conferences
May 21, 2025
·
1 min read
Press Releases
FDA Grants IND Clearance for Immunoglobulin Eye Drops to Treat Dry Eye Disease Patients in a Phase II Clinical Study
May 21, 2025
·
5 min read
Press Releases
Zomedica Launches Enhanced Equine Insulin Assay for the TRUFORMA(R) Diagnostic Platform Featuring an Extended Range and Automatic Sample Dilution
May 21, 2025
·
7 min read
Press Releases
Medtronic announces intent to separate Diabetes business
May 21, 2025
·
9 min read
Press Releases
ME Therapeutics Receives Support to Advance mRNA Therapeutic Candidates for Cancer and Inflammatory Disease
May 21, 2025
·
4 min read
1 of 84,861
Next
